ALNYLAM PHARMACEUTICALS, INC.: net_income

Value{"amount": -440242000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001178670-24-000008
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/net-income/2023-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/2d9f9469-95e0-4ed8-a999-eeced3941a1a

History